{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:18:18Z","timestamp":1790986698167,"version":"4.1.0"},"reference-count":53,"publisher":"Informa Healthcare","issue":"sup1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1517\/14712598.5.1.s29","type":"journal-article","created":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T10:00:19Z","timestamp":1127901619000},"page":"S29-S36","source":"Crossref","is-referenced-by-count":23,"title":["Variability factors in the clinical response to recombinant antibodies and IgG Fc-containing fusion proteins"],"prefix":"10.1517","volume":"5","author":[{"given":"Herv\u00e9","family":"Watier","sequence":"first","affiliation":[{"name":"Universit\u00e9 Fran\u00e7ois-Rabelais de Tours, EA 3853 IPGA (Immuno-Pharmaco-Genetics of therapeutic Antibodies), Facult\u00e9 de M\u00e9decine, 10 Boulevard Tonnell\u00e9, 37032 TOURS cedex, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2005,11,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"TEILLAUD JL: Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges. Expert Opia Biol. Ther. (20005) 5\\(Suppl. 1):S-S.","DOI":"10.1517\/14712598.5.1.S15"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)01034-5"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1038\/nrd984"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1386"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/72601"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125002171"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"R149\u2013R155","DOI":"10.1186\/ar1465","volume":"7","author":"MAROTTE H","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"CIT0008","first-page":"2350","volume":"97","author":"MARTINEZ-BORRA J","year":"2002","journal-title":"Am. J. Castroenterol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/art.11168"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.526"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"CRIS WELL LA, LUM RE TURNER KN,et al.: The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. (2004) 50:2750\u20132756.","DOI":"10.1002\/art.20469"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/art.10719"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/art.20154"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1080\/gas.37.7.818.824"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.9.1013"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.119763"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"WEBER AA, JACOBS C, MEILA D et a\/.:No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein inhibitors. Pharmacogenetics (2002) 12:581\u2013583.","DOI":"10.1097\/00008571-200210000-00011"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"GORCHAKOVA 0, KOCH W, MEHILLI J etal. PIA polymorphism of the glycoprotein Ma and efficacy of reperfusion therapy in patients with acute myocardial infarction. Thromb. Haemost. (2004) 91:141\u2013145.","DOI":"10.1160\/TH03-06-0341"},{"key":"CIT0019","first-page":"1927","volume":"1998","author":"COIFFIER B","journal-title":"Blood"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008416911099"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V99.4.1314","volume":"99","author":"PEDERSEN IM","year":"2002","journal-title":"Blood"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"MANCHES 0, LUI G, CHAPEROT L et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood (2003) 101:949\u2013954.","DOI":"10.1182\/blood-2002-02-0469"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3383"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1639"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1200\/JCO.2001.19.10.2587","volume":"19","author":"SEIDMAN AD","year":"2001","journal-title":"Clin. Oncol"},{"key":"CIT0026","first-page":"S33\u2013S49","volume":"121","author":"WINSTON JS","year":"2004","journal-title":"J. Pathol"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.06.022"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1023\/B:DRUG.0000006173.72210.1c"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.754"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.013"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1002\/art.10764"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.059"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2548"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0651"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3929"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01871.x"},{"key":"CIT0037","first-page":"1067","volume":"71","author":"RICHEZ C","year":"2004","journal-title":"Rev Rhum"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"CRIS WELL LA, LUM RF, TURNER KNet al.: The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. (2004) 50:2750\u20132756.","DOI":"10.1002\/art.20469"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.148"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","volume":"90","author":"KOENE HR","year":"1997","journal-title":"Blood"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119616"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.01.007"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2862"},{"key":"CIT0044","first-page":"1274","volume":"89","author":"SALMON JE","year":"1992","journal-title":"Independent mechanisms for differences in human phagocyte function. J. Clin. Invest."},{"key":"CIT0045","first-page":"172","volume":"5","author":"PENDLEY C","year":"2003","journal-title":"Curr. Opin. Mol. Ther."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200405000-00008"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.6.2153"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.171"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009483200"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1038\/6179"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202069200"},{"key":"CIT0053","doi-asserted-by":"crossref","unstructured":"NIWA R, HATANAKA S, SHOJI6HOSAKA E et al.: Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 is independent of FcyRIIIa functional polymorphism. Clin. Cancer Res. (2004) 10:6248\u20136255.","DOI":"10.1158\/1078-0432.CCR-04-0850"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.5.1.S29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T05:30:36Z","timestamp":1597469436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.5.1.S29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":53,"journal-issue":{"issue":"sup1","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["10.1517\/14712598.5.1.S29"],"URL":"https:\/\/doi.org\/10.1517\/14712598.5.1.s29","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}